Harmful somatic amino acid substitutions affect key pathways in cancers

Area of Science:

• Genomics
• Cancer Biology
• Bioinformatics

Background:

• Cancer is driven by genetic variations, but distinguishing functional from non-functional alterations is challenging.
• Current cancer genomics often focuses on identifying specific 'cancer genes', overlooking the vast number of non-functional variations.
• Recurrent somatic variations, potential cancer drivers, are found in a small subset of patients.

Purpose of the Study:

• To analyze amino acid substitutions (AASs) across diverse cancer types to identify functional variations.
• To investigate the role of proteins with harmful AASs in cancer-related pathways.
• To compare the efficacy of pathway-based analysis versus gene/variation-based analysis in cancer research.

Main Methods:

• Analyzed 6,861 cancer samples (whole genome/exome sequencing) across 30 cancer types.
• Performed pathway enrichment analysis on proteins with harmful amino acid substitutions (AASs).
• Examined overlaps between cancers based on affected proteins and pathways.

Main Results:

• Only 39.88% of AASs were identified as harmful, even within known cancer genes.
• Proteins with harmful AASs are often central to protein interaction networks.
• Significantly affected pathways were identified in 28 cancer types, demonstrating pathway-level impact despite AAS frequency.
• Pathway analysis revealed greater benefit than focusing on individual genes or variations.

Conclusions:

• Harmful AAS-affected pathways illuminate critical cancer development processes.
• The developed approach filters benign AASs, enabling reliable identification of key cancer pathways.
• Identified pathways offer new avenues for experimental research and targeted cancer therapies.